ZIPRECRUITER, INC. (ZIP) Spending and interest coverage
- R&D / revenue · 12 months: Value 24.69%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 7.99%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 24.69% | Research and development expense / revenue. Period ending 2026-06-30. $111.66M ÷ $452.26M × 100 ≈ 24.69% |
| Stock-based compensation / revenue · 12 months | 7.99% | Share-based compensation / revenue. Period ending 2026-06-30. $36.15M ÷ $452.26M × 100 ≈ 7.99% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 111.66M USD | Research and Development Expense |
| Revenue | 452.26M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 36.15M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 1.56M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $111.66M | $452.26M | $36.15M | $1.56M | (m) | 24.69% | 7.99% | (m) | (m) |
| 2026-03-31 | $117.38M | $446.43M | $41.39M | $-9.24M | (m) | 26.29% | 9.27% | (m) | (m) |
| 2025-12-31 | $124.56M | $448.95M | $47.65M | $-19.36M | (m) | 27.75% | 10.61% | (m) | (m) |
| 2025-09-30 | $127.95M | $448.30M | $53.50M | $-27.37M | (m) | 28.54% | 11.93% | (m) | (m) |
| 2025-06-30 | $130.81M | $450.40M | $57.47M | $-25.59M | (m) | 29.04% | 12.76% | (m) | (m) |
| 2025-03-31 | $132.02M | $461.83M | $60.45M | $-9.50M | (m) | 28.59% | 13.09% | (m) | (m) |
| 2024-12-31 | $134.83M | $474.00M | $64.40M | $1.26M | (m) | 28.45% | 13.59% | (m) | (m) |
| 2024-09-30 | $135.84M | $498.90M | $75.13M | $18.57M | (m) | 27.23% | 15.06% | (m) | (m) |
| 2024-06-30 | $134.28M | $537.45M | $79.19M | $54.47M | (m) | 24.98% | 14.73% | (m) | (m) |
| 2024-03-31 | $139.58M | $584.21M | $81.24M | $67.57M | $29.41M | 23.89% | 13.91% | 2.30× | Reported |
| 2023-12-31 | $141.80M | $645.72M | $84.23M | $79.44M | $29.39M | 21.96% | 13.05% | 2.70× | Reported |
| 2023-09-30 | $143.21M | $720.28M | $77.78M | $94.59M | $29.38M | 19.88% | 10.80% | 3.22× | Reported |
| 2023-06-30 | $144.08M | $791.62M | $78.01M | $91.39M | $29.39M | 18.20% | 9.85% | 3.11× | Reported |
| 2023-03-31 | $136.39M | $861.14M | $78.03M | $93.96M | $29.55M | 15.84% | 9.06% | 3.18× | Reported |
| 2022-12-31 | $127.74M | $904.65M | $76.96M | $97.23M | $28.50M | 14.12% | 8.51% | 3.41× | Reported |
| 2022-09-30 | $121.97M | $914.31M | $77.11M | $94.28M | $21.38M | 13.34% | 8.43% | 4.41× | Reported |
| 2022-06-30 | $116.11M | $900.01M | $79.82M | $82.78M | $14.24M | 12.90% | 8.87% | 5.81× | Reported |
| 2022-03-31 | $123.10M | $843.03M | $126.53M | $-10.63M | $6.99M | 14.60% | 15.01% | -1.52× | Reported |
| 2021-12-31 | $110.47M | $741.14M | $107.26M | $-8.39M | $916.00K | 14.91% | 14.47% | -9.16× | Reported |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $69.41M | $418.14M | $5.75M | $64.43M | $1.04M | 16.60% | 1.38% | 62.13× | Reported |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $65.41M | $429.56M | $6.74M | $-6.32M | $575.00K | 15.23% | 1.57% | -10.99× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.